The source of circulating selenoprotein S and its association with type 2 diabetes mellitus and atherosclerosis: a preliminary study

Table 1 Clinical and laboratory characteristics of the study population

Group	Gender	Age^{a, b, c}	WC^{a, c, d, e}	BMI^{a, c, d, e}	SBP^{a, b, c, e}	DBP
Group	(Male/female)	(years)	(cm)	(kg/m²)	(mmHg)	(mmHg)
HC	27 (6/21)	56.22 ± 5.65	84.69 ± 9.98	24.16 ± 2.50	119.85 ± 13.56	77.44 ± 7.59
ISAS	22 (9/13)	56.73 ± 7.52	83.92 ± 10.44	24.64 ± 2.61	129.05 ± 12.67	80.14 ± 9.14
IAS	27 (13/14)	56.52 ± 6.72	87.13 ± 6.77	25.98 ± 2.67	129.07 ± 14.80	80.44 ± 6.91
IDM	24 (12/12)	49.71 ± 5.03	94.00 ± 9.03	26.91 ± 3.54	129.58 ± 17.32	81.25 ± 10.03
DSAS	29 (14/15)	58.17 ± 7.87	93.57 ± 10.01	26.14 ± 3.62	138.41 ± 17.39	81.00 ± 8.78
DAS	29 (14/15)	61.48 ± 7.88	98.28 ± 6.84	26.77 ± 2.93	141.10 ± 15.65	79.93 ± 8.56

Group	HbA1c	FPG^e	Sqrt (TG)^{a, d, e}	TC	LDL-C	HDL-C
Group	(%)	(mmol/L)	(mmol/L)	(mmol/L)	(mmol/L)	(mmol/L)
HC	–	5.37 ± 0.43	1.29 ± 0.40	5.45 ± 0.85	3.11 ± 0.63	1.29 ± 0.20
ISAS	–	5.23 ± 0.16	1.21 ± 0.24	5.02 ± 0.89	2.81 ± 0.48	1.21 ± 0.20
IAS	–	5.16 ± 0.40	1.23 ± 0.25	4.46 ± 1.15	2.54 ± 0.85	1.10 ± 0.27
IDM	8.42 ± 1.65	8.64 ± 2.85	1.38 ± 0.32	4.84 ± 1.20	2.72 ± 0.75	1.19 ± 0.30
DSAS	9.14 ± 1.89	7.90 ± 2.07	1.15 ± 0.25	4.51 ± 0.73	2.57 ± 0.56	1.12 ± 0.17
DAS	9.05 ± 1.42	9.32 ± 3.56	1.36 ± 0.46	5.07 ± 1.18	2.93 ± 0.82	1.23 ± 0.29

HC, ISAS, IAS, IDM, DSAS, and DAS represent the healthy control group, the isolated subclinical AS group, the isolated AS group, the isolated DM group, the diabetes complicated with SAS group and the diabetes complicated with AS group, respectively
^asignificantly different among non-AS, SAS, and AS at P < 0.05 based on ANOVA
^bsignificantly different within groups between SAS and non-AS at P < 0.05 based on the LSD method after ANOVA
^csignificantly different within groups between AS and non-AS at P < 0.05 based on the LSD method after ANOVA
^dsignificantly different within groups between SAS and AS at P < 0.05 based on the LSD method after ANOVA
^esignificantly different between subjects with and without T2DM

ISSN: 1475-2840